CompletedPhase 2NCT04518124

Propranolol in Angiosarcoma

Studying Angiosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Netherlands Cancer Institute
Principal Investigator
Winan van Houdt, MD PhD, MD, PhD
Netherlands Cancer Institute - Antoni van Leeuwenhoek
Intervention
Propranolol(drug)
Enrollment
14 enrolled
Eligibility
18 years · All sexes
Timeline
2019 – 2023

Study locations (1)

Collaborators

Anticancer Fund, Belgium

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04518124 on ClinicalTrials.gov

Other trials for Angiosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Angiosarcoma →

← Back to all trials